Pharma BD Deal Intelligence
Thermo Fisher Scientific Inc. / Dionex Corporation
2010 · Acquisition/Merger · $2.1B · Complete
Announcement Sentiment
88
Strongly positive
Thermo Fisher to acquire Dionex for $118.50/share cash, ~$2.1B. Strengthens chromatography portfolio complementing mass spec/LIMS leadership.
Did it work? Outcome assessment
Strategic verdict
Achieved Stated Rationale
Financial impact
Accretive
Pipeline outcome
Assets Advanced
Assessment window: 10yr post-close.
Key facts
- Announced Dec 13, 2010
- Closed May 16, 2011
- Deal value $2.1B
- Deal type Acquisition/Merger
- Therapeutic area Life sciences/diagnostics analytical tools
- Indications Life sciences/diagnostics analytical tools
- Key assets Ion chromatography instruments and consumables
- Mechanism Chromatography platform
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals